Cargando…
The Prognostic Value of Periostin Expression in Non-Small Cell Lung Cancer: A Meta-Analysis
BACKGROUND: Non-small cell lung cancer (NSCLC) is one of the leading causes of cancer-related death in the world and its poor prognosis is a major concern. Periostin was found to be associated with the prognosis of NSCLC. However, the research results were inconsistent. This meta-analysis evaluated...
Autores principales: | Li, Mengjie, Ma, Guangzhi, Li, Xuebing, Zhou, Qinghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341396/ https://www.ncbi.nlm.nih.gov/pubmed/35891604 http://dx.doi.org/10.12659/MSM.936898 |
Ejemplares similares
-
Prognostic value of lymphocyte-to-monocyte ratio among Asian lung cancer patients: a systematic review and meta-analysis
por: Li, Wen, et al.
Publicado: (2017) -
Prognostic Value of Pretreatment D-Dimer Level in Small-Cell Lung Cancer: A Meta-Analysis
por: Li, Jialong, et al.
Publicado: (2021) -
Prognostic value of smoking status in non-small-cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis
por: Kim, Jung Han, et al.
Publicado: (2017) -
Prognostic significance of immune cells in non-small cell lung cancer: meta-analysis
por: Soo, Ross A., et al.
Publicado: (2018) -
Prognostic value of KRAS mutation in advanced non-small-cell lung cancer treated with immune checkpoint inhibitors: A meta-analysis and review
por: Kim, Jung Han, et al.
Publicado: (2017)